tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 133 are a BUY (96.38%), 5 are a HOLD (3.62%).
Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 32.65% that have a potential upside of 40.29% achieved within 109 days.
Geulah Livshits’s has documented 266 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KRYS, Krystal Biotech at 18-Dec-2024.
Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) at 12/8/2020. The price target of $46 was fulfilled within 1 day with a profit of $13.97 (43.62%) receiving and performance score of 436.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$86
$45.61 (112.92%)
$86
1 days ago
(20-Dec-2024)
10/13 (76.92%)
$45.61 (112.92%)
170
Buy
$94
$53.61 (132.73%)
$94
11 days ago
(10-Dec-2024)
3/12 (25%)
$44.53 (90.01%)
27
Hold
$55
$14.61 (36.17%)
$59
1 months 15 days ago
(06-Nov-2024)
10/15 (66.67%)
$4.81 (9.58%)
101
Buy
$84
$43.61 (107.97%)
$84
1 months 15 days ago
(06-Nov-2024)
8/16 (50%)
$33.81 (67.36%)
214
Hold
$53
$12.61 (31.22%)
$53
1 months 15 days ago
(06-Nov-2024)
9/11 (81.82%)
$2.81 (5.60%)
180
Which stock is Geulah Livshits is most bullish on?
Which stock is Geulah Livshits is most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
